ATTN LogoMenu
4JAZZTier 5
Articles

Jazz Pharmaceuticals plc 4

0001188919-26-000012

View on SEC EDGAR

Non-employee director Ted W. Love received an award of 1,605 restricted stock units of Jazz Pharmaceuticals plc ordinary shares.

On August 5, 2026, Ted W. Love, a non-employee director of Jazz Pharmaceuticals plc, received a grant of 1,605 restricted stock units representing ordinary shares under the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan; these units, which carry no purchase price, will vest in full on July 23, 2027, subject to his continued service and other conditions, bringing his direct ownership to 3,132 ordinary shares following the award.

Filing Facts

CIK
1232524
Ticker
JAZZ
Form
4
Source Type
fda
Accession
0001188919-26-000012
Alert Tier
5
Jazz Pharmaceuticals plc 4 | ATTN